Early research (Phase 1)Study completedNCT03552536
What this trial is testing
MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002)
Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 5